|
|
적색스테인
|
|
 |
lYVnQOLvxGWou |
 |
380 |
|
 |
| What line of work are you in? http://tiava.in.net/ www.tiava.com The brokerage, which forecasts peak sales of $1.4 billion assuming a 40 percent new PAH patient share at a 15 percent price discount to Tracleer and Gilead Sciences' rival drug Letairis, also raised its price target to 79 francs from 71 francs. |
|
 |
Gerry |
 |
2020-01-19 13:25:06 |
|
|
|
|
|
|
|
|
|
